Suchergebnisse - "Subbiah, Vivek"

PubPharm (568)

71

Utility of Established Prognostic Scoring Systems for Patients with Advanced Pancreatic Adenocarcinoma Enrolled in Immunotherapy-Based Early-Phase Clinical Trials

enthalten in: International journal of gastrointestinal cancer | 2023

von Surana, R. | Gonzalez, G. | Rogers, J. | +9

72

Phase I study of sapanisertib with carboplatin and paclitaxel in mTOR pathway altered solid malignancies

enthalten in: NPJ precision oncology | 2023

von Alhalabi, O. | Groisberg, R. | Zinner, R. | +18

73

The abscopal effect in patients with cancer receiving immunotherapy

enthalten in: Med (New York, N.Y.) | 2023

von Nelson, B. | Adashek, J. | Lin, S. | +1

74

Clouds across the new dawn for clinical, diagnostic and biological data: accelerating the development, delivery and uptake of personalized medicine

enthalten in: Diagnosis | 2023

von Horgan, D. | Capoluongo, E. | Dube, F. | +10

75

Surgery After BRAF-Directed Therapy Is Associated with Improved Survival in BRAFV600E Mutant Anaplastic Thyroid Cancer : A Single-Center Retrospective Cohort Study

enthalten in: Thyroid : official journal of the American Thyroid Association | 2023

von Zhao, X. | Wang, J. | Dadu, R. | +20

CommentIn: Thyroid. 2023 Apr;33(4):402-403. - PMID 36856459

76

On target methods to induce abscopal phenomenon for Off-Target effects : From happenstance to happenings

enthalten in: Cancer medicine | 2023

von Nelson, B. | Adashek, J. | Lin, S. | +1

77

Dabrafenib plus trametinib in patients with relapsed/refractory BRAF V600E mutation-positive hairy cell leukemia

enthalten in: Blood | 2023

von Kreitman, R. | Moreau, P. | Ravandi, F. | +14

CommentIn: Blood. 2023 Mar 2;141(9):965-966. - PMID 36862436

78

Dabrafenib plus trametinib in patients with relapsed/refractory BRAF V600E mutation-positive hairy cell leukemia

enthalten in: Blood | March 2, 2023

von Kreitman, R. | Moreau, P. | Ravandi, F. | +14

79

Impact of tissue-agnostic approvals for patients with gastrointestinal malignancies

enthalten in: Trends in cancer | 2023

von Bhamidipati, D. | Subbiah, V.

80

Accelerating cancer omics and precision oncology in health care and research : a Lancet Oncology Commission

enthalten in: The Lancet. Oncology | 2023

von Casolino, R. | Johns, A. | Courtot, M. | +16